Sheikh, M., Cambre, E., Langreck, C., Javitch, J. A., & Canetta, S. E. (2025). Chronic administration of methocinnamox, a mu-opioid receptor antagonist, reduces hedonic response without impacting motivation in mice. Psychopharmacology, 242(10), 2327. https://doi.org/10.1007/s00213-025-06801-2
Chicago Style (17th ed.) CitationSheikh, Misbah, Emily Cambre, Cory Langreck, Jonathan A. Javitch, and Sarah E. Canetta. "Chronic Administration of Methocinnamox, a Mu-opioid Receptor Antagonist, Reduces Hedonic Response Without Impacting Motivation in Mice." Psychopharmacology 242, no. 10 (2025): 2327. https://doi.org/10.1007/s00213-025-06801-2.
MLA (9th ed.) CitationSheikh, Misbah, et al. "Chronic Administration of Methocinnamox, a Mu-opioid Receptor Antagonist, Reduces Hedonic Response Without Impacting Motivation in Mice." Psychopharmacology, vol. 242, no. 10, 2025, p. 2327, https://doi.org/10.1007/s00213-025-06801-2.